Author Question: A type of synchronous communcations that requires only a single line is Manchester encoding. ... (Read 131 times)

mpobi80

  • Hero Member
  • *****
  • Posts: 519
A type of synchronous communcations that requires only a single line is Manchester encoding.
 
  Indicate whether the statement is true or false

Question 2

What distinguishes the look-ahead-carry adder?
 
  A) It is easier to implement logically than a full-adder.
  B) It requires advance knowledge of the final answer.
  C) It is slower than the ripple-carry adder.
  D) It is faster than a ripple-carry adder.


brittanywood

  • Sr. Member
  • ****
  • Posts: 355
Answer to Question 1

TRUE

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library